Especially, AKT inhibition facilitates cell apoptosis in the presence of Ibrutinib and LINK-A, indicating that LINK-A contributes to Ibrutinib resistance of MCL cells, at least in part by regulating AKT-dependent target genes. This evidence concerns the gene LINC01139 and mantle cell lymphoma.